AlzProtect is a healthcare company, headquartered in France.
AlzProtect · Alzheimer therapy biotech. Xerys Series B EUR 14M 2017. Follow-on Term Sheet June 2023 EUR 5-10M at EUR 75M valuation.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Already a member? Sign in
Other portfolio companies in the same fund.
Comparable healthcare deals from other GPs.